Redhill Biopharma Ltd at UBS Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. And thank you for coming to the 2020 Virtual UBS Global Healthcare Conference. My name is Rebecca Johnson, and I'm happy to be your host for this session. Our next presenter will be Dror Ben-Asher, the CEO and Co-Founder of RedHill Biopharma. A Q&A session will follow immediately after the presentation. (Operator Instructions)
I'll now turn it over to Dror. Thank you.
Thank you, Rebecca, and thank you to the UBS team for inviting us. And good morning, everybody. I know it's early for you, and I appreciate you joining us at such an early hour in the beginning of your week, especially during such challenging times.
For lack of time, we'll focus today on a number of select items, including the large message associated with RedHill. We are on our way to become a leading spec pharma player in the United States. It's a very exciting journey for us. Potentially
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
